BR112019026846A2 - processo para preparar um lisado de plaquetas humanas agrupadas, lisado de plaquetas humanas agrupadas e seu uso para tratar transtornos neurológicos - Google Patents

processo para preparar um lisado de plaquetas humanas agrupadas, lisado de plaquetas humanas agrupadas e seu uso para tratar transtornos neurológicos Download PDF

Info

Publication number
BR112019026846A2
BR112019026846A2 BR112019026846-4A BR112019026846A BR112019026846A2 BR 112019026846 A2 BR112019026846 A2 BR 112019026846A2 BR 112019026846 A BR112019026846 A BR 112019026846A BR 112019026846 A2 BR112019026846 A2 BR 112019026846A2
Authority
BR
Brazil
Prior art keywords
phpl
treatment
treated
fact
platelet lysate
Prior art date
Application number
BR112019026846-4A
Other languages
English (en)
Portuguese (pt)
Inventor
David DeVos
Thier­Ry Burnouf
Jean-Christophe Deved­Jian
Ming-Li Chou
Flore GOUEL
Original Assignee
INSERM (Institut National de la Santé et de la Recherche Médicale)
Centre Hospitalier Regional Et Universitaire De Lille (Chru)
Universite De Lille
Universite Du Littoral Cote D'opale
Taipei Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INSERM (Institut National de la Santé et de la Recherche Médicale), Centre Hospitalier Regional Et Universitaire De Lille (Chru), Universite De Lille, Universite Du Littoral Cote D'opale, Taipei Medical University filed Critical INSERM (Institut National de la Santé et de la Recherche Médicale)
Publication of BR112019026846A2 publication Critical patent/BR112019026846A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR112019026846-4A 2017-06-16 2018-06-15 processo para preparar um lisado de plaquetas humanas agrupadas, lisado de plaquetas humanas agrupadas e seu uso para tratar transtornos neurológicos BR112019026846A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17305739 2017-06-16
EP17305739.9 2017-06-16
PCT/EP2018/066020 WO2018229278A1 (en) 2017-06-16 2018-06-15 Process for preparing a pooled human platelet lysate, pooled human platelet lysate and its use for treating neurological disorders

Publications (1)

Publication Number Publication Date
BR112019026846A2 true BR112019026846A2 (pt) 2020-06-30

Family

ID=59269973

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019026846-4A BR112019026846A2 (pt) 2017-06-16 2018-06-15 processo para preparar um lisado de plaquetas humanas agrupadas, lisado de plaquetas humanas agrupadas e seu uso para tratar transtornos neurológicos

Country Status (10)

Country Link
US (1) US11744863B2 (https=)
EP (1) EP3638263B1 (https=)
JP (1) JP7370870B2 (https=)
CN (1) CN110891582A (https=)
AU (1) AU2018284011B2 (https=)
BR (1) BR112019026846A2 (https=)
CA (1) CA3067294A1 (https=)
ES (1) ES2955282T3 (https=)
IL (1) IL271436B2 (https=)
WO (1) WO2018229278A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI744300B (zh) * 2016-03-23 2021-11-01 里爾中央醫學中心 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途
EP3920944A4 (en) * 2019-02-07 2023-03-29 Biobridge Global METHODS AND COMPOSITIONS RELATED TO PLATELET RELEASTAT AND PLATELET-RICH FIBRIN
EP3881858A1 (en) * 2020-03-20 2021-09-22 Rok Pangersic Heat-treated platelet-derived growth factor extract for use in a method of preventing or treating a tissue defect
WO2023103744A1 (zh) * 2021-12-07 2023-06-15 无限发展有限公司 血小板内生长因子的提取方法
EP4276173A1 (en) 2022-05-10 2023-11-15 Stemmatters, Biotecnologia e Medicina Regenerativa, S.A. Stable human platelet lysate composition, methods and uses thereof
AU2022489599A1 (en) * 2022-12-02 2025-07-17 Nuwacell Biotechnologies Co., Ltd. Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
TWI909123B (zh) 2022-12-30 2025-12-21 思必瑞特生技股份有限公司 含血小板之組合物及其製備方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2006632A6 (es) 1987-04-21 1989-05-01 Green Cross Corp Procedimiento de tratamiento termico de fibrinogeno.
GB0512401D0 (en) * 2005-06-17 2005-07-27 Randox Lab Ltd Method
WO2008034803A1 (en) * 2006-09-18 2008-03-27 Medizinische Universität Graz Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics
EP2077118A1 (en) * 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Clottable concentrate of platelet growth factors and preparation method thereof
ES2402144T3 (es) * 2010-05-25 2013-04-29 Gwowei Technology Co., Ltd. Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
CA2840568C (en) 2011-06-27 2021-05-04 Emory University Compositions, uses, and preparation of platelet lysates
US20140176602A1 (en) 2011-08-18 2014-06-26 Nec Corporation Information processing system, information processing method, information processing apparatus, and control method and control program thereof
AU2013365623B2 (en) * 2012-12-20 2017-08-24 Omrix Biopharmaceuticals Ltd. Viral inactivated biological mixture
WO2015031465A1 (en) 2013-08-27 2015-03-05 Cook General Biotechnology Llc Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same

Also Published As

Publication number Publication date
US11744863B2 (en) 2023-09-05
US20200113942A1 (en) 2020-04-16
EP3638263A1 (en) 2020-04-22
ES2955282T3 (es) 2023-11-29
EP3638263C0 (en) 2023-08-23
RU2020101295A3 (https=) 2022-02-24
CN110891582A (zh) 2020-03-17
AU2018284011B2 (en) 2024-05-30
IL271436B2 (en) 2024-02-01
JP2020523398A (ja) 2020-08-06
IL271436B1 (en) 2023-10-01
AU2018284011A1 (en) 2020-01-16
IL271436A (en) 2020-01-30
WO2018229278A1 (en) 2018-12-20
EP3638263B1 (en) 2023-08-23
RU2020101295A (ru) 2021-07-16
JP7370870B2 (ja) 2023-10-30
CA3067294A1 (en) 2018-12-20

Similar Documents

Publication Publication Date Title
ES2955282T3 (es) Proceso para preparar un lisado de plaquetas humanas combinadas y su uso para el tratamiento de trastornos neurológicos
ES2545193T3 (es) Extracto de plaquetas inactivado viral, uso y preparación del mismo
AU2017238476B2 (en) Preparation of platelet pellet lysate and its use for treating neurological disorders
Yuan et al. Combined bioscaffold with stem cells and exosomes can improve traumatic brain injury
BR112020006316A2 (pt) processo para preparar uma fração de lisado de plaquetas, fração de lisado de plaquetas e seu uso para tratar transtornos do sistema nervoso central
Hwang et al. Effect of coenzyme Q10 on spinal cord ischemia-reperfusion injury
Li et al. Influence of neural stem cell transplantation on angiogenesis in rats with spinal cord injury
CN102625707A (zh) Hip/pap或其衍生物的新应用
CN110755450B (zh) 间充质干细胞来源的细胞外囊泡在治疗蛛网膜下腔出血中的应用
RU2802440C2 (ru) Способ получения объединенного лизата тромбоцитов человека, объединенный лизат тромбоцитов человека и его применение для лечения неврологических нарушений
CN102813914A (zh) 一种用于治疗或预防脑血管及相关疾病的药物组合物
Jinbo et al. Olfactory ensheathing cell-conditioned medium protects astrocytes exposed to hydrogen peroxide stress
Shi et al. Bone marrow mesenchymal stem cell exosomes alleviate oxygen-glucose deprivation/reperfusion injury in hippocampal neurons
Goczyńska et al. Innovative applications of platelet derivatives in light of information presented during the 2022 virtual congress of the International Society of Blood Transfusion (ISBT); selected issues
CN102973522B (zh) 丹酚酸a冻干粉针用于制备挽救缺血半暗带药物的用途
HK1195486A (en) Viral inactivated platelet extract, use and preparation thereof

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]